Seven Eight Capital’s Novavax NVAX Stock Holding History

Seven Eight Capital’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-19,970	Closed	-$205K	–	558
2022 Q4	$205K	Sell	19,970 -5,705	-22%	-$101K	0.05%	371
2022 Q3	$467K	Buy	+25,675	New	+$1.11M	0.09%	292
2020 Q4	–	Sell	-2,340	Closed	-$254K	–	559
2020 Q3	$254K	Buy	+2,340	New	+$285K	0.05%	480
2016 Q4	–	Sell	-15,975	Closed	-$665K	–	625
2016 Q3	$665K	Buy	+15,975	New	+$2.06M	0.19%	178
2016 Q2	–	Hold	0	–	–	–	631
2016 Q1	–	Hold	0	–	–	–	641
2015 Q4	–	Sell	-270	Closed	-$38K	–	641
2015 Q3	$38K	Buy	+270	New	+$60.5K	0.03%	366

Other funds holding NVAX

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Seven Eight Capital's NVAX Position: Q1 2023 in Review

Seven Eight Capital sold out of Novavax (NVAX) in Q1 2023, closing a stake of 19,970 shares — an estimated $205K sold.

Seven Eight Capital first reported a position in NVAX in Q3 2015 and held it in 5 quarters. The position peaked at $665K in Q3 2016. 222 funds tracked by Wall St. Rank hold NVAX as of Q1 2023.

Seven Eight Capital reported no remaining Novavax position as of Q1 2023 after selling out during the quarter.
Seven Eight Capital sold 19,970 Novavax shares in Q1 2023, an estimated $205K.
Seven Eight Capital first reported a position in Novavax in Q3 2015 and held it in 5 quarters.
Seven Eight Capital's Novavax position peaked at $665K in Q3 2016.
222 funds tracked by Wall St. Rank held Novavax as of Q1 2023.

Based on Seven Eight Capital's 13F filing for Q1 2023, filed 15 May 2023.